IC
Ikarian Capital Portfolio holdings
AUM
$302M
This Quarter Return
+0.65%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$560M
AUM Growth
+$560M
(-17%)
Cap. Flow
-$113M
Cap. Flow
% of AUM
-20.13%
Top 10 Holdings %
Top 10 Hldgs %
31.32%
Holding
256
New
15
Increased
27
Reduced
52
Closed
40
Top Buys
| 1 |
Biogen
BIIB
|
$41.6M |
| 2 |
CRISPR Therapeutics
CRSP
|
$16.9M |
| 3 |
Alector
ALEC
|
$8.69M |
| 4 |
Cullinan Oncology
CGEM
|
$7.59M |
| 5 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$6.31M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$27.4M |
| 2 |
IMAB
I-MAB
IMAB
|
$17.1M |
| 3 |
Curis
CRIS
|
$13.8M |
| 4 |
Prothena Corp
PRTA
|
$11M |
| 5 |
Celldex Therapeutics
CLDX
|
$7.72M |
Sector Composition
| 1 | Healthcare | 96.31% |
| 2 | Technology | 0.53% |
| 3 | Consumer Staples | 0.24% |
| 4 | Financials | 0.14% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Pliant Therapeutics
PLRX
$105M
| $3.17M | 0.26% |
108,700
| – | – |
|
52
Viking Therapeutics
VKTX
$3.02B
| $3.14M | 0.25% |
524,754
-200,000
| -28% | -$1.2M |
|
|
BLU
53
DELISTED
BELLUS Health Inc.
BLU
| $3.14M | 0.25% |
1,010,545
+610,545
| +153% | +$1.9M |
|
54
Incyte
INCY
$17B
| $3.07M | 0.25% |
36,533
+13,521
| +59% | +$1.14M |
|
55
BioAtla
BCAB
$28.7M
| $2.97M | 0.24% |
70,160
| – | – |
|
|
TAOX
56
Tao Synergies Inc. Common Stock
TAOX
$20.9M
| $2.96M | 0.24% |
+300,000
| New | +$2.96M |
|
57
Avalo Therapeutics
AVTX
$139M
| $2.93M | 0.24% |
897,330
| – | – |
|
58
VistaGen Therapeutics
VTGN
$113M
| $2.89M | 0.23% |
916,552
-1,969,400
| -68% | -$6.2M |
|
59
Ascendis Pharma
ASND
$12.1B
| $2.87M | 0.23% |
21,825
-40,265
| -65% | -$5.3M |
|
|
WHWK
60
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
| $2.83M | 0.23% |
1,676,093
-975,000
| -37% | -$1.65M |
|
61
GeneDx Holdings
WGS
$3.65B
| $2.8M | 0.23% |
+200,000
| New | +$2.8M |
|
62
Eledon Pharmaceuticals
ELDN
$155M
| $2.77M | 0.22% |
350,000
+100,000
| +40% | +$791K |
|
63
Disc Medicine
IRON
$2.14B
| $2.76M | 0.22% |
426,455
-257,924
| -38% | -$1.67M |
|
|
ALLK
64
DELISTED
Allakos
ALLK
| $2.71M | 0.22% |
31,700
| – | – |
|
|
ALPN
65
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $2.7M | 0.22% |
300,454
-4,285
| -1% | -$38.6K |
|
|
HEPA
66
DELISTED
Hepion Pharmaceuticals
HEPA
| $2.7M | 0.22% |
+1,365,059
| New | +$2.7M |
|
67
Savara
SVRA
$591M
| $2.7M | 0.22% |
1,586,737
-127,629
| -7% | -$217K |
|
68
Immatics
IMTX
$662M
| $2.61M | 0.21% |
225,138
-30,000
| -12% | -$348K |
|
69
INmune Bio
INMB
$52.4M
| $2.58M | 0.21% |
146,883
-86,693
| -37% | -$1.52M |
|
|
KA
70
DELISTED
Kineta, Inc. Common Stock
KA
| $2.56M | 0.21% |
219,470
| – | – |
|
71
Liquidia Corp
LQDA
$2.52B
| $2.55M | 0.21% |
890,435
-60,965
| -6% | -$174K |
|
72
Gyre Therapeutics
GYRE
$734M
| $2.52M | 0.2% |
581,200
| – | – |
|
73
Sutro Biopharma
STRO
$85.6M
| $2.52M | 0.2% |
135,360
| – | – |
|
74
Solid Biosciences
SLDB
$448M
| $2.47M | 0.2% |
675,675
+652,058
| +2,761% | +$2.39M |
|
75
Cytokinetics
CYTK
$5.98B
| $2.39M | 0.19% |
120,895
-6,105
| -5% | -$121K |
|